Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Crinetics Pharmaceuticals Inc buy SVB Leerink LLC

Crinetics Pharmaceuticals Inc
Start price
€38.40
29.09.25 / 50%
Target price
€75.07
29.09.26
Performance (%)
86.93%
Price
€71.78
11:06
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC for Crinetics Pharmaceuticals Inc has seen massive gains of 86.93%. This prediction currently runs until 29.09.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Crinetics Pharmaceuticals Inc 0.192% 0.192%
iShares Core DAX® 1,00 % 4,83 %
iShares Nasdaq 100 2,70 % -1,72 %
iShares Nikkei 225® 3,52 % -3,51 %
iShares S&P 500 1,77 % 1,27 %

Comments by SVB_Leerink_LLC for this prediction

In the thread Crinetics Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 86.93%
Target price 75.073
Change
Ends at 29.09.26

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target raised by analysts at Leerink Partners from $80.00 to $88.00. They now have an "outperform" rating on the stock.
Ratings data for CRNX provided by MarketBeat

SVB Leerink LLC 
0
Report Share
29.09.25